These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 16249906)

  • 1. Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action.
    Uzunova V; Sampson L; Uzunov DP
    Psychopharmacology (Berl); 2006 Jun; 186(3):351-61. PubMed ID: 16249906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroactive steroids in depression and anxiety disorders: clinical studies.
    Eser D; Schüle C; Baghai TC; Romeo E; Rupprecht R
    Neuroendocrinology; 2006; 84(4):244-54. PubMed ID: 17159334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of neuroactive steroids before and after electroconvulsive therapy in major depression.
    Baghai TC; di Michele F; Schüle C; Eser D; Zwanzger P; Pasini A; Romeo E; Rupprecht R
    Neuropsychopharmacology; 2005 Jun; 30(6):1181-6. PubMed ID: 15702138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; di Michele F; Schüle C; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Neuroscience; 2006; 138(3):1041-8. PubMed ID: 16310959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties.
    Rupprecht R
    Psychoneuroendocrinology; 2003 Feb; 28(2):139-68. PubMed ID: 12510009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?
    Schüle C; Eser D; Baghai TC; Nothdurfter C; Kessler JS; Rupprecht R
    Neuroscience; 2011 Sep; 191():55-77. PubMed ID: 21439354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders.
    Eser D; Schüle C; Romeo E; Baghai TC; di Michele F; Pasini A; Zwanzger P; Padberg F; Rupprecht R
    Psychopharmacology (Berl); 2006 Jun; 186(3):373-87. PubMed ID: 16247651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroactive steroids as modulators of depression and anxiety.
    Eser D; Romeo E; Baghai TC; Schüle C; Zwanzger P; Rupprecht R
    Expert Rev Endocrinol Metab; 2006 Jul; 1(4):517-526. PubMed ID: 30290461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of allopregnanolone in depression and anxiety.
    Schüle C; Nothdurfter C; Rupprecht R
    Prog Neurobiol; 2014 Feb; 113():79-87. PubMed ID: 24215796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroactive steroids and affective disorders.
    Eser D; Schüle C; Baghai TC; Romeo E; Uzunov DP; Rupprecht R
    Pharmacol Biochem Behav; 2006 Aug; 84(4):656-66. PubMed ID: 16831459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
    Schüle C; Romeo E; Uzunov DP; Eser D; di Michele F; Baghai TC; Pasini A; Schwarz M; Kempter H; Rupprecht R
    Mol Psychiatry; 2006 Mar; 11(3):261-72. PubMed ID: 16344854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.
    Hirani K; Sharma AN; Jain NS; Ugale RR; Chopde CT
    Psychopharmacology (Berl); 2005 Jul; 180(2):267-78. PubMed ID: 15719223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression.
    Padberg F; di Michele F; Zwanzger P; Romeo E; Bernardi G; Schüle C; Baghai TC; Ella R; Pasini A; Rupprecht R
    Neuropsychopharmacology; 2002 Nov; 27(5):874-8. PubMed ID: 12431862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
    Ströhle A; Romeo E; di Michele F; Pasini A; Hermann B; Gajewsky G; Holsboer F; Rupprecht R
    Arch Gen Psychiatry; 2003 Feb; 60(2):161-8. PubMed ID: 12578433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature.
    McEvoy K; Payne JL; Osborne LM
    Curr Psychiatry Rep; 2018 Aug; 20(9):78. PubMed ID: 30094520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral action of ethanol in Porsolt's forced swim test: modulation by 3 alpha-hydroxy-5 alpha-pregnan-20-one.
    Hirani K; Khisti RT; Chopde CT
    Neuropharmacology; 2002 Dec; 43(8):1339-50. PubMed ID: 12527484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological markers of rapid antidepressant effects of allopregnanolone.
    Lambert PM; Lu X; Zorumski CF; Mennerick S
    J Neuroendocrinol; 2022 Feb; 34(2):e13023. PubMed ID: 34423498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms.
    Maitra R; Reynolds JN
    Can J Physiol Pharmacol; 1998 Sep; 76(9):909-20. PubMed ID: 10066142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroactive steroids as endogenous modulators of anxiety.
    Eser D; Baghai TC; Schüle C; Nothdurfter C; Rupprecht R
    Curr Pharm Des; 2008; 14(33):3525-33. PubMed ID: 19075729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.